e-learning
resources
Amsterdam 2015
Wednesday, 30.09.2015
COPD: notable points
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Circulating levels of IGF-I and IGFBP-3 in patients with COPD
Ümran Toru (Kütahya, Turkey), Ümran Toru, Ceylan Ayada, Osman Genç, Server Sahin, Özlem Arik, Ismet Bulut
Source:
International Congress 2015 – COPD: notable points
Session:
COPD: notable points
Session type:
Poster Discussion
Number:
4810
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ümran Toru (Kütahya, Turkey), Ümran Toru, Ceylan Ayada, Osman Genç, Server Sahin, Özlem Arik, Ismet Bulut. Circulating levels of IGF-I and IGFBP-3 in patients with COPD. Eur Respir J 2015; 46: Suppl. 59, 4810
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Klotho expression is reduced in COPD
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013
miRNA-145 & SMAD3 expression in patients with COPD
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
Serum levels of leptin and visfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Different data in COPD
Year: 2015
Increased circulating endothelial microparticles in COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Serum transforming growth factor –β1 (TGF-β1) in asthmatics: Association between disease control, severity and duration
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Presence of progranulin in airway inflammation associated with COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Decreased hyaluronan in airway smooth muscle cells of asthma and COPD patients
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD
Year: 2009
Serum levels of RAAS components in COPD
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Increased serum level of apelin in chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome
Source: International Congress 2015 – COPD: notable points
Year: 2015
Circulating endothelin-1 levels in patients with COPD
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Effect of pulmonary rehabilitation on muscle inflammation and muscle insulin-like growth factor-I in COPD
Source: Annual Congress 2006 - Physiological responses to rehabilitation
Year: 2006
IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Secretion of hyaluronic acid is mediated by muscarinic receptors in airway smooth muscle cells of patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Targeting ASK1 in preventing airway smooth muscle growth: Implications for airway remodeling in COPD
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD
Source: Eur Respir J 2009; 34: 616
Year: 2009
Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 652s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept